Back to search

National and Kapodistrian University of Athens

Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη

Abstract

dc:description

The aim of our study was to analyze the possible relationships between treatment efficacy, and germinal gene polymorphisms linked to the irinotecan in combination with bevasizumab or panitumumab and capecitabine or 5-FU that has been routinely used in our practice, in the management of metastatic colorectal cancer (CRC).MATERIALS AND METHODS:Ninety-four Greek with histologically proven metastatic CRC were included in the study. Treatment was administered until disease progression or unacceptable toxicity, for a maximum of eight cycles. Patients were stratified into stable disease. (SD) and progressive disease. (PD). Associations between clinical data, KRAS, UGT1A1. (UGT1A1*28) and DPD (IVS14+1 G. > A) polymorphisms, and toxicity were analyzed.RESULTS:Fifty-eight (61.70%) patients were characterized with SD disease and 36 (38.30%) with PD. There were not statistical significant differences between carriers of KRAS mutated alleles between SD and PD groups. No significant difference was found between response rates and toxicity and DPD or UGT1A1 genotypes. Our results suggested that determination of DPD or UGT1A1 genotypes could not be useful for predicting severe toxicity of irinotecan in our population.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Isaakidou, Athina
  • Ισαακίδου, Αθηνά

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38016

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Isaakidou, Athina; Ισαακίδου, Αθηνά. Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη. National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/38016